These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14559808)

  • 1. Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine.
    Lee WP; Tai DI; Tsai SL; Yeh CT; Chao Y; Lee SD; Hung MC
    Cancer Res; 2003 Oct; 63(19):6229-36. PubMed ID: 14559808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARP14 promotes the proliferation and gemcitabine chemoresistance of pancreatic cancer cells through activation of NF-κB pathway.
    Yao N; Chen Q; Shi W; Tang L; Fu Y
    Mol Carcinog; 2019 Jul; 58(7):1291-1302. PubMed ID: 30968979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases.
    Matsumoto K; Nagahara T; Okano J; Murawaki Y
    Oncol Rep; 2008 Oct; 20(4):863-72. PubMed ID: 18813828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells.
    Jacob DA; Bahra M; Langrehr JM; Boas-Knoop S; Stefaniak R; Davis J; Schumacher G; Lippert S; Neumann UP
    J Gastroenterol Hepatol; 2007 May; 22(5):738-48. PubMed ID: 17444865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional down-regulation of poly(ADP-ribose) polymerase gene expression by E1A binding to pRb proteins protects murine keratinocytes from radiation-induced apoptosis.
    Pacini A; Quattrone A; Denegri M; Fiorillo C; Nediani C; Ramon y Cajal S; Nassi P
    J Biol Chem; 1999 Dec; 274(49):35107-12. PubMed ID: 10574992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase.
    Boulakia CA; Chen G; Ng FW; Teodoro JG; Branton PE; Nicholson DW; Poirier GG; Shore GC
    Oncogene; 1996 Feb; 12(3):529-35. PubMed ID: 8637709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylenimine (PEI)-Mediated E1A Increases the Sensitivity of Hepatocellular Carcinoma Cells to Chemotherapy.
    Li Z; Yao Z; Zhang Y; Yao J; Pan Z; Chen J
    Med Sci Monit Basic Res; 2019 Apr; 25():113-120. PubMed ID: 30956277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.
    Rundall BK; Denlinger CE; Jones DR
    Surgery; 2005 Aug; 138(2):360-7. PubMed ID: 16153448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.
    Wirth T; Kühnel F; Fleischmann-Mundt B; Woller N; Djojosubroto M; Rudolph KL; Manns M; Zender L; Kubicka S
    Cancer Res; 2005 Aug; 65(16):7393-402. PubMed ID: 16103092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma.
    Wang H; Satoh M; Chen GP; Li DC; Hamada H; Arai Y
    Chin Med J (Engl); 2011 Apr; 124(7):1082-7. PubMed ID: 21542972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles.
    Muñoz-Gámez JA; López Viota J; Barrientos A; Carazo Á; Sanjuán-Nuñez L; Quiles-Perez R; Muñoz-de-Rueda P; Delgado Á; Ruiz-Extremera Á; Salmerón J
    Liver Int; 2015 Apr; 35(4):1430-41. PubMed ID: 24821649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer.
    Wang Y; Kuramitsu Y; Tokuda K; Baron B; Kitagawa T; Akada J; Maehara S; Maehara Y; Nakamura K
    PLoS One; 2014; 9(10):e109076. PubMed ID: 25271986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.
    Denlinger CE; Rundall BK; Keller MD; Jones DR
    Ann Thorac Surg; 2004 Oct; 78(4):1207-14; discussion 1207-14. PubMed ID: 15464472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS- Mediated Signalling Pathways.
    Wu W; Xia Q; Luo RJ; Lin ZQ; Xue P
    Asian Pac J Cancer Prev; 2015; 16(10):4369-76. PubMed ID: 26028101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non-small-cell lung cancer.
    Jiang Y; Dai H; Li Y; Yin J; Guo S; Lin SY; McGrail DJ
    Int J Cancer; 2019 Mar; 144(5):1092-1103. PubMed ID: 30152517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
    Luo Q; Li Y; Lai Y; Zhang Z
    J Toxicol Sci; 2015 Jun; 40(3):349-63. PubMed ID: 25972196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor 1 deficiency worsens hepatocellular carcinoma, while gemcitabine treatment alleviates the hepatocellular carcinoma-induced increase in intra-hepatic immune cells.
    Chu CS; Chen HP; Lin PH; Cheng CC; Kuo HY; Fan PH; Peng WH; Wu LL
    J Gastroenterol Hepatol; 2024 Oct; 39(10):2208-2218. PubMed ID: 39005010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway.
    Ji DG; Guan LY; Luo X; Ma F; Yang B; Liu HY
    Biochem Biophys Res Commun; 2018 Jun; 501(1):33-40. PubMed ID: 29702091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma.
    Zai W; Chen W; Han Y; Wu Z; Fan J; Zhang X; Luan J; Tang S; Jin X; Fu X; Gao H; Ju D; Liu H
    Carcinogenesis; 2020 May; 41(3):345-357. PubMed ID: 31175354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.